KR20040063083A - 천연두 백신 - Google Patents

천연두 백신 Download PDF

Info

Publication number
KR20040063083A
KR20040063083A KR10-2003-7013866A KR20037013866A KR20040063083A KR 20040063083 A KR20040063083 A KR 20040063083A KR 20037013866 A KR20037013866 A KR 20037013866A KR 20040063083 A KR20040063083 A KR 20040063083A
Authority
KR
South Korea
Prior art keywords
vaccinia virus
strain
dryvax
clone
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR10-2003-7013866A
Other languages
English (en)
Korean (ko)
Inventor
리차드 에이. 웰친
토마스 피이. 모나쓰
Original Assignee
아캠비스, 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아캠비스, 인크. filed Critical 아캠비스, 인크.
Publication of KR20040063083A publication Critical patent/KR20040063083A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A61K39/285—Vaccinia virus or variola virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24161—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR10-2003-7013866A 2001-04-23 2002-04-23 천연두 백신 Ceased KR20040063083A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/840,751 US6723325B1 (en) 2001-04-23 2001-04-23 Smallpox vaccine
US09/840,751 2001-04-23
PCT/US2002/012616 WO2002085411A1 (en) 2001-04-23 2002-04-23 Smallpox vaccine

Publications (1)

Publication Number Publication Date
KR20040063083A true KR20040063083A (ko) 2004-07-12

Family

ID=25283120

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2003-7013866A Ceased KR20040063083A (ko) 2001-04-23 2002-04-23 천연두 백신

Country Status (19)

Country Link
US (2) US6723325B1 (https=)
EP (1) EP1381389B1 (https=)
JP (1) JP4397591B2 (https=)
KR (1) KR20040063083A (https=)
CN (1) CN1527722A (https=)
AU (1) AU2002258910B2 (https=)
BR (1) BR0209145A (https=)
CA (1) CA2444747C (https=)
CZ (1) CZ305819B6 (https=)
EA (1) EA007656B1 (https=)
ES (1) ES2546612T3 (https=)
HU (1) HU228401B1 (https=)
IL (2) IL158549A0 (https=)
MA (1) MA26270A1 (https=)
MX (1) MXPA03009711A (https=)
NZ (1) NZ529265A (https=)
PL (1) PL212117B1 (https=)
WO (1) WO2002085411A1 (https=)
ZA (1) ZA200309084B (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7645456B2 (en) * 2001-04-23 2010-01-12 Sanofi Pasteur Biologics Co. Vaccinia virus strains
US6723325B1 (en) * 2001-04-23 2004-04-20 Acambis, Inc. Smallpox vaccine
US20090269365A1 (en) * 2005-04-20 2009-10-29 University Of Washington Immunogenic vaccinia peptides and methods of using same
MX2009004862A (es) 2006-11-07 2009-07-17 Sanofi Pasteur Biologics Co Estabilizacion de vacunas por liofilizacion.
KR100859345B1 (ko) * 2006-12-12 2008-09-19 씨제이제일제당 (주) 세포배양에 의해 두창 백신을 생산하는 방법 및 그에 의해생산된 두창 백신
ES2733211T3 (es) * 2011-04-15 2019-11-28 Genelux Corp Cepas clonales de virus vaccinia atenuados y métodos de uso de las mismas
RU2496149C1 (ru) * 2012-06-19 2013-10-20 Федеральное бюджетное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" (ФБУН ГНЦ ВБ "Вектор") Способ оценки противооспенной активности лечебно-профилактических препаратов
JP2019535311A (ja) 2016-11-02 2019-12-12 デイビッド エバンス， 合成キメラポックスウイルス
EP3788142A4 (en) 2018-05-02 2022-04-27 Tonix Pharma Holdings Limited SYNTHETIC CHIMERIC VACCINE VIRUS
US11505782B2 (en) 2018-06-04 2022-11-22 Calidi Biotherapeutics, Inc. Cell-based vehicles for potentiation of viral therapy
CA3116192C (en) 2018-11-06 2025-09-23 Calidi Biotherapeutics (Nevada), Inc. IMPROVED SYSTEMS FOR CELL-MEDIATED ONCOLYTIC VIRAL THERAPY
WO2025184411A1 (en) 2024-02-27 2025-09-04 Calidi Biotherapeutics (Nevada), Inc. Serum-resistant eev viruses and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4315914A (en) * 1980-04-04 1982-02-16 Seiji Arakawa Pharmaceutical compositions useful as cellular immunopotentiator and antitumor agent and process for production thereof
JPS60202827A (ja) 1984-03-28 1985-10-14 Chibaken 弱毒痘そうワクチン株
US5614193A (en) * 1991-11-14 1997-03-25 The United States Of America As Represented By The Secretary Of The Army Hantavirus vaccine
US5656465A (en) * 1994-05-04 1997-08-12 Therion Biologics Corporation Methods of in vivo gene delivery
US6723325B1 (en) 2001-04-23 2004-04-20 Acambis, Inc. Smallpox vaccine

Also Published As

Publication number Publication date
US7115270B2 (en) 2006-10-03
JP4397591B2 (ja) 2010-01-13
EP1381389A1 (en) 2004-01-21
HUP0303878A3 (en) 2010-01-28
ES2546612T3 (es) 2015-09-25
WO2002085411A1 (en) 2002-10-31
MXPA03009711A (es) 2005-03-07
US6723325B1 (en) 2004-04-20
PL373958A1 (en) 2005-09-19
AU2002258910B2 (en) 2007-10-25
EP1381389B1 (en) 2015-08-26
CA2444747A1 (en) 2002-10-31
US20060153873A1 (en) 2006-07-13
CZ20033184A3 (cs) 2004-04-14
ZA200309084B (en) 2005-01-26
HU228401B1 (en) 2013-03-28
CA2444747C (en) 2018-04-17
PL212117B1 (pl) 2012-08-31
NZ529265A (en) 2006-04-28
HK1062804A1 (zh) 2004-11-26
EA007656B1 (ru) 2006-12-29
EA200301151A1 (ru) 2004-10-28
IL158549A (en) 2009-07-20
MA26270A1 (fr) 2004-09-01
BR0209145A (pt) 2005-04-19
IL158549A0 (en) 2004-05-12
HUP0303878A2 (hu) 2004-03-01
CN1527722A (zh) 2004-09-08
EP1381389A4 (en) 2004-07-28
JP2005503126A (ja) 2005-02-03
CZ305819B6 (cs) 2016-03-30

Similar Documents

Publication Publication Date Title
US20090324548A1 (en) Vaccinia Virus Strains
Eckels et al. Japanese encephalitis virus live-attenuated vaccine, Chinese strain SA14-14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use
AU2003239805B2 (en) Modified vaccinia virus ankara for the vaccination of neonates
KR20040063083A (ko) 천연두 백신
US20090017068A1 (en) Vaccines against West Nile Virus
AU2002258910A1 (en) Smallpox vaccine
JP2012501350A (ja) ウエストナイルウイルスワクチン
AU2003298277B2 (en) Vaccines against West Nile Virus
US4569840A (en) Thymidine kinase-negative temperature resistant bovine herpesvirus-1 mutant as a vaccine against infectious bovine rhinotracheitis
HK1062804B (en) Smallpox vaccine
EP0119025B1 (en) Thymidine kinase-negative temperature resistant bovine herpesvirus-1 mutant as a vaccine against infectious bovine rhinotracheitis
EP1558726B1 (en) Vaccines against west nile virus
US20220175908A1 (en) Methods for Inducing a Safe Immune Response Against Polio Virus
RU2136312C1 (ru) Способ иммунизации против инфекции, вызываемой вирусом клещевого энцефалита
WO2024248170A1 (ko) 아프리카돼지열병 바이러스 배양을 위한 세포주 및 이를 이용한 백신
KR20250170922A (ko) 아프리카돼지열병 바이러스 배양을 위한 세포주 및 이의 용도
KR100859345B1 (ko) 세포배양에 의해 두창 백신을 생산하는 방법 및 그에 의해생산된 두창 백신
HK1078777B (en) Modified vaccinia virus ankara for the vaccination of neonates

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20031023

Patent event code: PA01051R01D

Comment text: International Patent Application

AMND Amendment
PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20070420

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20080204

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20090224

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20080204

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

J201 Request for trial against refusal decision
PJ0201 Trial against decision of rejection

Patent event date: 20090529

Comment text: Request for Trial against Decision on Refusal

Patent event code: PJ02012R01D

Patent event date: 20090224

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Appeal kind category: Appeal against decision to decline refusal

Decision date: 20100930

Appeal identifier: 2009101004900

Request date: 20090529

AMND Amendment
PB0901 Examination by re-examination before a trial

Comment text: Amendment to Specification, etc.

Patent event date: 20090626

Patent event code: PB09011R02I

Comment text: Request for Trial against Decision on Refusal

Patent event date: 20090529

Patent event code: PB09011R01I

Comment text: Amendment to Specification, etc.

Patent event date: 20081104

Patent event code: PB09011R02I

Comment text: Amendment to Specification, etc.

Patent event date: 20040518

Patent event code: PB09011R02I

B601 Maintenance of original decision after re-examination before a trial
E801 Decision on dismissal of amendment
PB0601 Maintenance of original decision after re-examination before a trial

Comment text: Report of Result of Re-examination before a Trial

Patent event code: PB06011S01D

Patent event date: 20090810

PE0801 Dismissal of amendment

Patent event code: PE08012E01D

Comment text: Decision on Dismissal of Amendment

Patent event date: 20090810

Patent event code: PE08011R01I

Comment text: Amendment to Specification, etc.

Patent event date: 20090626

Patent event code: PE08011R01I

Comment text: Amendment to Specification, etc.

Patent event date: 20081104

Patent event code: PE08011R01I

Comment text: Amendment to Specification, etc.

Patent event date: 20040518

J301 Trial decision

Free format text: TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20090529

Effective date: 20100930

PJ1301 Trial decision

Patent event code: PJ13011S01D

Patent event date: 20100930

Comment text: Trial Decision on Objection to Decision on Refusal

Appeal kind category: Appeal against decision to decline refusal

Request date: 20090529

Decision date: 20100930

Appeal identifier: 2009101004900